ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (A1LN34)

82.10
3.10
(3.92%)
Closed January 27 3:55PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 335.04M319.29M318.75M750.53M439.72M494.33M659.83M500.92M
Operating Income -188.61M-149.81M-229.83M213.87M-116.4M-43.44M48.61M-76.91M
Pre Tax Income -207.02M-172.36M-274.21M150.74M-137.69M-63.59M-11.17M-108.66M
Net Income -207.49M-174.1M-276.02M147.75M-137.87M-65.94M-16.89M-111.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -73.95M-153.32M-273.99M156.21M-136.76M-49.47M-15.6M-528.36M
EBITDA -174.3M-135.74M-216.65M227.2M-102.92M-29.92M63.62M-62.92M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 47.16M89.91M74.91M219.75M492.85M844.29M1.04B1.83B
Operating Income -424.59M-500.09M-814.67M-939.43M-828.44M-708.65M-785.07M-282.18M
Pre Tax Income -410.11M-490.87M-760.67M-885.25M-855.6M-852.14M-1.13B-433.52M
Net Income -410.11M-490.87M-761.5M-886.12M-858.28M-852.82M-1.13B-440.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.772-4.925-7.526-7.898-7.372-7.096-9.128-3.508
EBIT -418.42M-503.11M-789.94M-918.7M-782.91M-727.96M-791.28M-407.86M
EBITDA -414.99M-488.19M-801.87M-922.83M-798.24M-661.09M-740.6M-228.12M